Viridian Therapeutics, Inc. (VRDN) ownership: insiders 5% · institutions 107% · index and ETF funds 5% (13F 2026-03-31). Insider activity, 90 days: 2 sales, 0 open-market buys. SEC EDGAR first-party data.
| Holder | Shares | Market Value | % Outstanding | Reported |
|---|---|---|---|---|
| FMR (Fidelity) | 15379377.00 | $300.82M | 14.9% | 2026-03-31 |
| BlackRock | 7831475.00 | $153.18M | 7.6% | 2026-03-31 |
| Bellevue Group AG | 6726144.00 | $131.56M | 6.5% | 2026-03-31 |
| Vanguard | 6494969.00 | $127.04M | 6.3% | 2026-03-31 |
| State Street | 4672885.00 | $91.40M | 4.5% | 2026-03-31 |
| Fairmount Funds Management LLC | 3914458.00 | $76.57M | 3.8% | 2026-03-31 |
| Venrock Adviser, LLC | 3882709.00 | $75.95M | 3.8% | 2026-03-31 |
| Paradigm Biocapital Advisors LP | 3148893.00 | $61.59M | 3.1% | 2026-03-31 |
| Insider | Transaction | Value | Date |
|---|---|---|---|
| Sell | null | 2026-08-19 | |
| Sell | null | 2026-08-19 | |
| Sell | null | 2026-08-19 | |
| Sell | null | 2026-08-19 | |
| Sell | null | 2026-08-14 | |
| Sell | null | 2026-08-14 | |
| Sell | null | 2026-07-01 | |
| Sell | null | 2026-07-01 |
Back to VRDN overview · VRDN earnings · All congressional trades
Institutional data from SEC Form 13F. Insider data from SEC Form 4. Congressional data from STOCK Act disclosures. Not personalized investment advice.